Arif Ali Awan[Author] - Search Results

Year	Number of Results
2019	2
2020	2
2021	2
2022	1
2023	2
2024	2

1

Young Women with Breast Cancer: The Current Role of Precision Oncology.

Srikanthan A, Awan AA, McGee S, Rushton M. Srikanthan A, et al. Among authors: awan aa. J Pers Med. 2023 Nov 20;13(11):1620. doi: 10.3390/jpm13111620. J Pers Med. 2023. PMID: 38003935 Free PMC article. Review.

2

A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management.

Shah H, Surujballi J, Awan AA, Hutton B, Arnaout A, Shorr R, Vandermeer L, Alzahrani MJ, Clemons M. Shah H, et al. Among authors: awan aa. Breast Cancer Res Treat. 2021 Feb;185(3):533-547. doi: 10.1007/s10549-020-06009-2. Epub 2020 Nov 6. Breast Cancer Res Treat. 2021. PMID: 33156490 Review.

3

Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT).

Basulaiman B, Awan AA, Fergusson D, Vandermeer L, Arnaout A, Hilton J, Hutton B, Joy AA, Robinson A, Califaretti N, Stober C, Sienkiewicz M, Thavorn K, Clemons M. Basulaiman B, et al. Among authors: awan aa. Breast Cancer Res Treat. 2019 Aug;177(1):93-101. doi: 10.1007/s10549-019-05274-0. Epub 2019 May 24. Breast Cancer Res Treat. 2019. PMID: 31127468 Review.

4

Development of a comprehensive approach to adult hereditary cancer testing in Ontario.

Bell KA, Kim R, Aronson M, Gillies B, Ali Awan A, Chun K, Hart J, Healey R, Kim L, Klaric G, Panabaker K, Sabatini PJB, Sadikovic B, Selvarajah S, Smith AC, Stockley TL, Vaags AK, Eisen A, Pollett A, Feilotter H. Bell KA, et al. Among authors: ali awan a. J Med Genet. 2023 Aug;60(8):769-775. doi: 10.1136/jmg-2022-108945. Epub 2022 Dec 23. J Med Genet. 2023. PMID: 36564171

5

The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care.

Beltran-Bless AA, Clemons M, Vandermeer L, El Emam K, Ng TL, McGee S, Awan AA, Pond G, Renaud J, Barton G, Hutton B, Savard MF. Beltran-Bless AA, et al. Among authors: awan aa. Curr Oncol. 2024 Mar 6;31(3):1376-1388. doi: 10.3390/curroncol31030104. Curr Oncol. 2024. PMID: 38534937 Free PMC article.

6

Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study.

Awan AA, Saunders D, Pond G, Hamm C, Califaretti N, Mates M, Kumar V, Ibrahim MFK, Beltran-Bless AA, Vandermeer L, Hilton J, Clemons M. Awan AA, et al. Curr Oncol. 2024 Feb 27;31(3):1278-1290. doi: 10.3390/curroncol31030096. Curr Oncol. 2024. PMID: 38534929 Free PMC article.

7

Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey.

AlZahrani M, Clemons M, Vandermeer L, Sienkiewicz M, Awan AA, Hutton B, Pond GR, Ng TL. AlZahrani M, et al. Among authors: awan aa. J Bone Oncol. 2020 Nov 10;26:100339. doi: 10.1016/j.jbo.2020.100339. eCollection 2021 Feb. J Bone Oncol. 2020. PMID: 33294318 Free PMC article.

8

De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis.

Awan AA, Hutton B, Hilton J, Mazzarello S, Van Poznak C, Vandermeer L, Bota B, Stober C, Sienkiewicz M, Fergusson D, Shorr R, Clemons M. Awan AA, et al. Breast Cancer Res Treat. 2019 Aug;176(3):507-517. doi: 10.1007/s10549-019-05265-1. Epub 2019 May 11. Breast Cancer Res Treat. 2019. PMID: 31079283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year